Janus Henderson Investors US’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$81M Sell
683,413
-529,561
-44% -$60M 0.07% 338
2016
Q4
$122M Buy
1,212,974
+740,925
+157% +$79.4M 0.1% 254
2016
Q3
$59.6M Buy
472,049
+401,708
+571% +$49.6M 0.05% 396
2016
Q2
$8.22M Sell
70,341
-351,543
-83% -$39.8M 0.01% 695
2016
Q1
$43.7M Sell
421,884
-487,250
-54% -$47.1M 0.04% 449
2015
Q4
$90.6M Sell
909,134
-91,641
-9% -$8.97M 0.08% 299
2015
Q3
$91.3M Sell
1,000,775
-97,416
-9% -$9.77M 0.08% 299
2015
Q2
$116M Buy
1,098,191
+63,117
+6% +$6.98M 0.1% 288
2015
Q1
$118M Sell
1,035,074
-2,016,789
-66% -$230M 0.1% 270
2014
Q4
$336M Buy
3,051,863
+21,374
+0.7% +$2.25M 0.29% 87
2014
Q3
$296M Buy
3,030,489
+797,787
+36% +$78.5M 0.27% 95
2014
Q2
$225M Buy
2,232,702
+2,124,449
+1,962% +$207M 0.21% 137
2014
Q1
$9.94M Buy
108,253
+7,725
+8% +$712K 0.01% 674
2013
Q4
$9.1M Sell
100,528
-42,696
-30% -$3.69M 0.01% 682
2013
Q3
$11.4M Buy
143,224
+7,058
+5% +$556K 0.01% 622
2013
Q2
$9.91M Buy
+136,166
New +$10.2M 0.01% 619

Other funds holding ZBH

Janus Henderson Investors US's ZBH Position: Q1 2017 in Review

Janus Henderson Investors US reduced its Zimmer Biomet (ZBH) stake by 44% in Q1 2017, selling an estimated $60M and leaving 683,413 shares worth $81M. The position accounts for 0.07% of the portfolio, ranked #338.

Janus Henderson Investors US first reported a position in ZBH in Q2 2013 and has held it in 16 quarters since. The position peaked at $336M in Q4 2014. 817 funds tracked by Wall St. Rank hold ZBH as of Q1 2017.

  • Janus Henderson Investors US held 683,413 shares of Zimmer Biomet worth $81M as of Q1 2017.
  • Janus Henderson Investors US sold 529,561 Zimmer Biomet shares in Q1 2017, an estimated $60M.
  • Zimmer Biomet made up 0.07% of Janus Henderson Investors US's portfolio in Q1 2017, its #338 holding.
  • Janus Henderson Investors US first reported a position in Zimmer Biomet in Q2 2013 and has held it in 16 quarters since.
  • Janus Henderson Investors US's Zimmer Biomet position peaked at $336M in Q4 2014.
  • 817 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.